Arcturus Therapeutics Inc. announced its launch from incubator Johnson & Johnson Innovation Center as it expands operations at a new office and laboratory space in the Torrey Ridge Science Center, 10628 Science Center Drive.
Previously Pfizer Labs, the new headquarters includes over 10,000 square feet of office and laboratory space which the company said is sufficient to support RNA drug discovery and development.
"The Arcturus story began at the cutting-edge Johnson & Johnson Innovation Center here in San Diego,” said Joseph Payne, president and CEO of Arcturus Therapeutics. “Today, we are 'graduating' from the incubator space and moving into top-tier facilities that will enable us to execute our vision of bringing transformational life-saving RNA medicines to patients. We are expanding our work force and hiring key individuals to help us develop premier RNA medicines, such as our lead rare disease drug candidate, LUNAR-101, for treatment of transthyretin-mediated amyloidosis."
Founded in 2013, Arcturus Therapeutics is focused on RNA medicines for the treatment of rare diseases. According to a company press release, Arcturus has developed a novel, potent and safe RNA Therapeutics platform called Lunar, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutics. The company owns Unlocked Nucleic Acid chemistry technology and 34 patents enabling the targeting of any gene in the human genome.